tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BMY Stock Latest News

Bristol Myers presents results from COLLIGO-HCM trial at ESC Congress
The FlyBristol Myers presents results from COLLIGO-HCM trial at ESC Congress
4d ago
BMY
Hold Rating for Bristol-Myers Squibb Amid Uncertain Revenue Projections and Fair Valuation
PremiumRatings
Hold Rating for Bristol-Myers Squibb Amid Uncertain Revenue Projections and Fair Valuation
8d ago
BMY
Bristol-Myers Squibb’s Promising Phase 3 Study on KarXT for Bipolar-I Disorder
PremiumCompany Announcements
Bristol-Myers Squibb’s Promising Phase 3 Study on KarXT for Bipolar-I Disorder
11d ago
BMY
Bristol-Myers Squibb’s New Lung Cancer Study: Potential Market Impact
PremiumCompany Announcements
Bristol-Myers Squibb’s New Lung Cancer Study: Potential Market Impact
11d ago
BMY
Bristol-Myers Squibb’s KarXT Study: A Potential Game-Changer in Schizophrenia Treatment
PremiumCompany Announcements
Bristol-Myers Squibb’s KarXT Study: A Potential Game-Changer in Schizophrenia Treatment
11d ago
BMY
Bristol-Myers Squibb’s Promising Study on Luspatercept for α-Thalassemia
PremiumCompany AnnouncementsBristol-Myers Squibb’s Promising Study on Luspatercept for α-Thalassemia
11d ago
BMY
Bristol-Myers Squibb’s New Alzheimer’s Study: Potential Market Impact
Premium
Company Announcements
Bristol-Myers Squibb’s New Alzheimer’s Study: Potential Market Impact
11d ago
BMY
Bristol-Myers Squibb’s Promising Alzheimer’s Study: A Potential Game-Changer?
Premium
Company Announcements
Bristol-Myers Squibb’s Promising Alzheimer’s Study: A Potential Game-Changer?
11d ago
BMY
Bristol-Myers Squibb’s New Study on Schizophrenia Treatment Satisfaction: What Investors Need to Know
PremiumCompany Announcements
Bristol-Myers Squibb’s New Study on Schizophrenia Treatment Satisfaction: What Investors Need to Know
11d ago
BMY
Bristol-Myers Squibb’s New Phase 1 Study: A Potential Game-Changer in Cancer Treatment?
PremiumCompany Announcements
Bristol-Myers Squibb’s New Phase 1 Study: A Potential Game-Changer in Cancer Treatment?
11d ago
BMY
Bristol-Myers Squibb’s Promising Phase 3 Alzheimer’s Study: A Potential Game-Changer?
PremiumCompany Announcements
Bristol-Myers Squibb’s Promising Phase 3 Alzheimer’s Study: A Potential Game-Changer?
11d ago
BMY
Bristol-Myers Squibb’s Luspatercept Study: Market Insights and Implications
PremiumCompany Announcements
Bristol-Myers Squibb’s Luspatercept Study: Market Insights and Implications
11d ago
BMY
Bristol-Myers Squibb’s New Lung Cancer Study: Market Implications and Progress
PremiumCompany AnnouncementsBristol-Myers Squibb’s New Lung Cancer Study: Market Implications and Progress
11d ago
BMY
Bristol-Myers Squibb’s Promising Phase 3 Study on Pulmonary Fibrosis: A Potential Game Changer?
Premium
Company Announcements
Bristol-Myers Squibb’s Promising Phase 3 Study on Pulmonary Fibrosis: A Potential Game Changer?
12d ago
BMY
Bristol-Myers Squibb’s New Study: A Potential Game Changer in Multiple Myeloma Treatment
Premium
Company Announcements
Bristol-Myers Squibb’s New Study: A Potential Game Changer in Multiple Myeloma Treatment
12d ago
BMY
Bristol-Myers Squibb’s Phase 3 Alzheimer’s Study: A Potential Game-Changer?
PremiumCompany Announcements
Bristol-Myers Squibb’s Phase 3 Alzheimer’s Study: A Potential Game-Changer?
13d ago
BMY
Bristol-Myers Squibb’s Promising Phase 3 Study on Deucravacitinib for SLE
PremiumCompany Announcements
Bristol-Myers Squibb’s Promising Phase 3 Study on Deucravacitinib for SLE
13d ago
BMY
Bristol-Myers Squibb’s TRIDENT-3 Trial: A Game Changer in Lung Cancer Treatment?
PremiumCompany Announcements
Bristol-Myers Squibb’s TRIDENT-3 Trial: A Game Changer in Lung Cancer Treatment?
13d ago
BMY
Bristol-Myers Squibb’s ELEMENT-MDS Trial: A New Horizon in Anemia Treatment?
PremiumCompany Announcements
Bristol-Myers Squibb’s ELEMENT-MDS Trial: A New Horizon in Anemia Treatment?
13d ago
BMY
Bristol-Myers Squibb’s New Study on Pancreatic Cancer Treatment: What Investors Need to Know
PremiumCompany AnnouncementsBristol-Myers Squibb’s New Study on Pancreatic Cancer Treatment: What Investors Need to Know
13d ago
BMY
Bristol-Myers Squibb’s KarXT Study: A Potential Game-Changer for Bipolar-I Disorder
Premium
Company Announcements
Bristol-Myers Squibb’s KarXT Study: A Potential Game-Changer for Bipolar-I Disorder
13d ago
BMY
Bristol-Myers Squibb’s Luspatercept Study: A Potential Game-Changer for Anemia Treatment
Premium
Company Announcements
Bristol-Myers Squibb’s Luspatercept Study: A Potential Game-Changer for Anemia Treatment
13d ago
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >